These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 12039980)
1. Blood pressure, cardiac, and renal responses to salt and deoxycorticosterone acetate in mice: role of Renin genes. Wang Q; Hummler E; Nussberger J; Clément S; Gabbiani G; Brunner HR; Burnier M J Am Soc Nephrol; 2002 Jun; 13(6):1509-16. PubMed ID: 12039980 [TBL] [Abstract][Full Text] [Related]
2. Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene. Peng H; Carretero OA; Alfie ME; Masura JA; Rhaleb NE Hypertension; 2001 Mar; 37(3):974-80. PubMed ID: 11244026 [TBL] [Abstract][Full Text] [Related]
3. Potassium supplementation reduces cardiac and renal hypertrophy independent of blood pressure in DOCA/salt mice. Wang Q; Domenighetti AA; Pedrazzini T; Burnier M Hypertension; 2005 Sep; 46(3):547-54. PubMed ID: 16103267 [TBL] [Abstract][Full Text] [Related]
4. Cortical and medullary hemodynamics in deoxycorticosterone acetate-salt hypertensive mice. Gross V; Lippoldt A; Bohlender J; Bader M; Hansson A; Luft FC J Am Soc Nephrol; 1998 Mar; 9(3):346-54. PubMed ID: 9513896 [TBL] [Abstract][Full Text] [Related]
5. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats. Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506 [TBL] [Abstract][Full Text] [Related]
6. β-Arrestin-Biased Agonist Targeting the Brain AT Zanaty M; Seara FAC; Nakagawa P; Deng G; Mathieu NM; Balapattabi K; Karnik SS; Grobe JL; Sigmund CD Hypertension; 2021 Feb; 77(2):420-431. PubMed ID: 33249862 [TBL] [Abstract][Full Text] [Related]
7. Deoxycorticosterone suppresses the effects of losartan in nitric oxide-deficient hypertensive rats. DE Gracia MC; Osuna A; O'Valle F; Del Moral RG; Wangensteen R; Del Rio CG; Vargas F J Am Soc Nephrol; 2000 Nov; 11(11):1995-2000. PubMed ID: 11053474 [TBL] [Abstract][Full Text] [Related]
8. Angiotensinergic signaling in the brain mediates metabolic effects of deoxycorticosterone (DOCA)-salt in C57 mice. Grobe JL; Buehrer BA; Hilzendeger AM; Liu X; Davis DR; Xu D; Sigmund CD Hypertension; 2011 Mar; 57(3):600-7. PubMed ID: 21263123 [TBL] [Abstract][Full Text] [Related]
9. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats. Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841 [TBL] [Abstract][Full Text] [Related]
10. Nitric oxide synthase and renin-angiotensin system gene expression in salt-sensitive and salt-resistant Sabra rats. Lippoldt A; Gross V; Schneider K; Hansson A; Nadaud S; Schneider W; Bader M; Yagil C; Yagil Y; Luft FC Hypertension; 1997 Sep; 30(3 Pt 1):409-15. PubMed ID: 9314425 [TBL] [Abstract][Full Text] [Related]
11. Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats. Dai SY; Peng W; Zhang YP; Li JD; Shen Y; Sun XF J Neuroinflammation; 2015 Mar; 12():47. PubMed ID: 25885968 [TBL] [Abstract][Full Text] [Related]
12. Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension. Ling YH; Krishnan SM; Chan CT; Diep H; Ferens D; Chin-Dusting J; Kemp-Harper BK; Samuel CS; Hewitson TD; Latz E; Mansell A; Sobey CG; Drummond GR Pharmacol Res; 2017 Feb; 116():77-86. PubMed ID: 27986554 [TBL] [Abstract][Full Text] [Related]
13. Plasma renin activity and changes in tissue angiotensin converting enzyme. Michel B; Grima M; Stephan D; Coquard C; Welsch C; Barthelmebs M; Imbs JL J Hypertens; 1994 May; 12(5):577-84. PubMed ID: 7930558 [TBL] [Abstract][Full Text] [Related]
14. Chronic blockade of neuronal nitric oxide synthase does not affect long-term control of blood pressure in normal, saline-drinking or deoxycorticosterone-treated rats. Wangensteen R; Sainz J; Rodríguez-Gomez I; Moreno JM; Osuna A; Vargas F Exp Physiol; 2003 Mar; 88(2):243-50. PubMed ID: 12621529 [TBL] [Abstract][Full Text] [Related]
15. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats. Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815 [TBL] [Abstract][Full Text] [Related]
16. Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension. Li W; Sullivan MN; Zhang S; Worker CJ; Xiong Z; Speth RC; Feng Y Hypertension; 2015 Feb; 65(2):352-61. PubMed ID: 25421983 [TBL] [Abstract][Full Text] [Related]
17. Genetic Ablation of Prorenin Receptor in the Rostral Ventrolateral Medulla Influences Blood Pressure and Hydromineral Balance in Deoxycorticosterone-Salt Hypertension. Mathieu NM; Fekete EM; Muskus PC; Brozoski DT; Lu KT; Wackman KK; Gomez J; Fang S; Reho JJ; Grobe CC; Vazirabad I; Mouradian GC; Hodges MR; Segar JL; Grobe JL; Sigmund CD; Nakagawa P Function (Oxf); 2023; 4(5):zqad043. PubMed ID: 37609445 [TBL] [Abstract][Full Text] [Related]
19. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system. Brown L; Duce B; Miric G; Sernia C J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S143-8. PubMed ID: 9892155 [TBL] [Abstract][Full Text] [Related]
20. Interaction between sodium intake, angiotensin II, and blood pressure as a cause of cardiac hypertrophy. Morgan T; Aubert JF; Brunner H Am J Hypertens; 2001 Sep; 14(9 Pt 1):914-20. PubMed ID: 11587158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]